Denmark urges EU to tighten Russian visa restrictions after alleged assassination plot
Denmark has urged European Union countries to introduce tougher travel restrictions on Russian nationals following allegations that Moscow's in...
A new long-acting preventive HIV drug, lenacapavir, could be available in the world’s poorest countries by late 2025 or early 2026, according to Hui Yang, head of supply operations at the Global Fund to Fight AIDS, Tuberculosis and Malaria.
According to Hui Yang of the Global Fund, lenacapavir, a new long-acting preventive HIV drug, may be available in the world’s poorest countries by late 2025 or early 2026.
The timeline depends on regulatory approvals from authorities like the U.S. Food and Drug Administration and the World Health Organization, Yang said.
Lenacapavir is already approved as a treatment for multi-drug resistant HIV in the U.S., where it costs around $42,250 for the first year of therapy. Recent clinical trials have also demonstrated its effectiveness in preventing HIV infection, prompting Gilead Sciences to seek global approval for this new use.
Yang stressed the need for low and middle-income countries to have timely access to the drug, stating, "We don't want...low and low-middle income countries to wait, to be at the back of the line." This issue has long been a barrier in the fight against HIV.
To ensure affordable access, the Global Fund is collaborating with the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR), along with funding from the Children’s Investment Fund Foundation and the Bill & Melinda Gates Foundation. Together, they aim to provide lenacapavir to at least two million people in participating countries over three years.
In October, Gilead signed agreements with six generic drugmakers to produce lenacapavir more affordably for 120 low and middle-income countries. However, the deal faced criticism for excluding some regions, particularly in Latin America. Yang stated that while no agreements have been finalized with Gilead or the generic producers, they will work with all involved companies.
European leaders backing Ukraine met in Berlin on Thursday 19 November and warned that no peace deal should be settled without them.
Three people have been killed and around 15 injured after Russian ballistic missiles struck three bridges over the Dnipro River in Kyiv, according to the Ukrainian capital’s mayor, Vitali Klitschko.
Azerbaijani President Ilham Aliyev met Vietnamese Prime Minister Le Minh Hung in Hanoi on 20 November, during a visit highlighting the longstanding friendship and growing strategic partnership between the two countries.
Britain and the European Union have reached an agreement to ease trade, expand opportunities for young people and deepen economic ties, in a major step towards rebuilding relations after Brexit.
Georgia has declared 22 November 2026 a national day of mourning following a deadly residential building collapse in the Kvemo Ponichala district of Tbilisi.
For the first time in more than a quarter of a century, the United States can no longer say it has eliminated measles as health experts warn the American outbreak reflects a collapse in trust in vaccines.
A new study in mice suggests the brain’s protective barrier does more than block harmful substances. It also delivers essential proteins from the body, a process that may break down early in Alzheimer’s disease and offer a new target for treatment.
Here's your AnewZ Daily Brief for the 5th of November, as health emergencies, humanitarian crises, political shifts, and cybersecurity threats put governments and essential services under pressure across the globe. Here are five stories worth your attention.
Kazakhstan plans to manufacture 494 types of medicines through eight major investment projects worth a combined $862 million, Health Minister Akmaral Alnazarova announced on 3 November, local media reported.
Dengue fever has killed more people in Bangladesh this year than in the whole of 2025, with October the deadliest month so far, data from Bangladesh's Health Ministry shows.
You can download the AnewZ application from Play Store and the App Store.
What is your opinion on this topic?
Leave the first comment